Metraipolis › archive › dc_863e80ad705a

Ceramide-Phospholipid Risk Score Associates With Cardiovascular Events and Is Lowered by Atorvastatin, Simvastatin, and Anti-PCSK9 Treatments — Europe PMC PMID:42429171

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42429171
DOI
10.1097/fjc.0000000000001817
License (as archived)
solo-consultazione
Archived
2026-10-08T04:30:53.120Z
SHA-256 of the archived text
c0b6b7236e3bc4f1731b0e7e2dff93149275f0f63d2cb395d0a6528ff2a3457e
Stable URL of this page
https://metraipolis.com/documento/dc_863e80ad705a

How to cite

Ceramide-Phospholipid Risk Score Associates With Cardiovascular Events and Is Lowered by Atorvastatin, Simvastatin, and Anti-PCSK9 Treatments — Europe PMC PMID:42429171 — Europe PMC (en), https://europepmc.org/article/MED/42429171 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_863e80ad705a (Metraipolis archive dc_863e80ad705a, sha256 c0b6b7236e3bc4f1731b0e7e2dff93149275f0f63d2cb395d0a6528ff2a3457e)
BibTeX
@misc{dc863e80ad705a,
  title = {Ceramide-Phospholipid Risk Score Associates With Cardiovascular Events and Is Lowered by Atorvastatin, Simvastatin, and Anti-PCSK9 Treatments — Europe PMC PMID:42429171},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42429171},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_863e80ad705a; sha256 c0b6b7236e3bc4f1731b0e7e2dff93149275f0f63d2cb395d0a6528ff2a3457e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42429171. Agents can read the archived copy with the MCP tool read_document.